Consider When You Buy Diet Pills


When you plan to buy diet pills online you are not only saving time and energy but you can also gain access to important information about the products you want to purchase. When you purchase slimming pills online the important factors that every customer should check in company or product websites are the details regarding side effects of taking the medication, the costs associated with the purchase like medical consultation and if they offer consultations with doctors. Aside from that you also have to know if the transaction with them online is secure and will protect your personal data.

Read more »

Koreans Overdose on Diet Pills


Korea's use of slimming pills and appetite suppressants ranks near the top in the world despite an obesity rate of 3.5 percent, only a quarter of the OECD's average 14.6 percent. Production and import of obesity drug Sibutramine rose 11 times from W4.4 billion in 2003 to W49 billion in 2008 (US$1=W1,140). The market for psychotropic appetite suppressants, which are categorized as narcotics by the International Narcotics Control Board, also grew four-fold. It is a paradox that one of the skinniest countries in the world consumes the largest amount of diet drugs.

Read more »

FDA Panel to Review Vivus Anti-Obesity Drug


Vivus Inc. said a Food and Drug Administration advisory committee is tentatively set to review the company's new-drug application for its experimental Qnexa obesity treatment. Chief Executive Leland Wilson said the July 15 review will mark a critical milestone for Qnexa and the company. Vivus is one of three drug developers hoping to get regulatory approval of new oral obesity treatments, along with Orexigen Therapeutics Inc. and Arena Pharmaceuticals Inc.

Read more »

FDA to Review VIVUS Drug


announced that the New Drug Application (NDA) for its obesity candidate, Qnexa, will be reviewed by the Endocrinologic and Metabolic Drugs advisory committee of the U.S. Food and Drug Administration (FDA) tentatively on July 15, 2010. The US regulatory authority accepted the NDA filed by VIVUS for Qnexa on March 1, 2010. The NDA was filed in December 2009. A response from the FDA should be out in the fourth quarter of 2010 (action date: Oct 28, 2010).

Read more »


User login

Swai Fish
Omega XL
Black Beans
Dijon Mustard
Pinto Beans
Bento Box

phentermine how weight loss fast
Side Effects of Phentermine

learn spanish app ipad apps for kids swift programming tutorial

phentermine online